BRD2 and polycystic ovary syndrome: Age (31.57 ± 6.72 vs. 30.80 ± 5.58; p=0.230), weight (77.41 ± 12.04 vs. 73.60 ± 11.47; p=0.829), body mass index (BMI; 30.67 ± 4.62 vs. 29.03 ± 4.84; p=0.710), and thyroid-stimulating hormone (TSH; 2.41 ± 0.31 vs. 2.23 ± 0.85; p=0.394) levels and LH/FSH ratio (1.18 ± 0.72 vs. 1.40 ± 0.88; p<0.001) were higher in non-PCOS than in PCOS women.